Department of Biotechnology, School of Engineering and Technology, Sharda University, P.C, 201310, Greater Noida, U.P, India.
Department of Chemistry, Indian Institute of Technology, HauzKhas, New Delhi, 110016, India.
Microb Pathog. 2020 Oct;147:104205. doi: 10.1016/j.micpath.2020.104205. Epub 2020 Apr 28.
A. baumannii has been considered as Priority-I as suggested by the World Health Organization (WHO) and the most critical pathogenic microorganism for causing nosocomial infection in imunno-compromised hospital-acquired patients due to multi-drug resistance (MDR). In the current study, we utilized "Computer-aided ligand-based virtual screening approach" for identification of promising molecules against Mur family proteins based on the known inhibitor (Naphthyl Tetronic Acids ((5Z)-3-(4-chlorophenyl)-4-hydroxy-5-(1-naphthylmethylene) furan-2(5H)-one)) of MurB from E. coli. The in-house library was prepared using a similarity search of a known inhibitor (Drug Bank ID: DB07296) against several relevant chemical databases. The molecules obtained from virtual screening of Naphthyl Tetronic Acids in-house library were successively subjected to physicochemical and ADMET screening. After this, the molecules which passed all the filters, subsequently subjected into interaction analysis with the drug target proteins (MurB, MurD, MurE and MurG) of A. baumanni and the results explained that four molecules were promising (CHEMBL468144, DB07296, Enamine_T5956969 and 54723243) for further molecular dynamics simulations. The free and ligand bounded proteins that undergone MD simulation are listed as follows: MurB, MurB-CHEMBL468144, MurB-DB07296, MurE, MurE-54723243, MurE-DB07296, MurD, MurD-Enamine_T5956969, MurD-DB07296, MurG, MurG-CHEMBL468144, and MurG-DB07296. Based on global and essential dynamics analysis, the stability order of molecules towards MurB (CHEMBL468144 > DB07296); MurD (Enamine_T5956969 > DB07296); MurE (54723243 > DB07296) and MurG (CHEMBL468144 > DB07296) indicates that the newly identified molecules are more promising one in comparison with the existing inhibitor. Based on all the docking and MD simulation results, the stability order of the free and ligand bounded protein are as follows; MurB and MurB-ligand complexes > MurD and MurD-ligand complexes > MurG and MurG-ligand complexes > MurE and MurE-ligand complexes. Finally, the selected compounds would be recommended for further experimental investigations and used as promising inhibitors of the infection caused by A. baumannii.
鲍曼不动杆菌被世界卫生组织(WHO)列为优先级-1,并且由于多药耐药性(MDR),是导致免疫受损医院获得性感染的最关键的致病性微生物。在本研究中,我们利用“基于配体的计算机辅助虚拟筛选方法”,基于大肠杆菌 MurB 的已知抑制剂(萘基四酮酸((5Z)-3-(4-氯苯基)-4-羟基-5-(1-萘基亚甲基)呋喃-2(5H)-酮)),针对 Mur 家族蛋白,从内部库中筛选出有前途的分子。内部库是使用对几种相关化学数据库的已知抑制剂(药物银行 ID:DB07296)进行相似性搜索制备的。从内部库的萘基四酮酸虚拟筛选中获得的分子依次经过物理化学和 ADMET 筛选。通过所有过滤器后,随后将这些分子与鲍曼不动杆菌的药物靶蛋白(MurB、MurD、MurE 和 MurG)进行相互作用分析,结果表明有四个分子很有前途(CHEMBL468144、DB07296、Enamine_T5956969 和 54723243),可进一步进行分子动力学模拟。进行 MD 模拟的自由和配体结合蛋白如下列出:MurB、MurB-CHEMBL468144、MurB-DB07296、MurE、MurE-54723243、MurE-DB07296、MurD、MurD-Enamine_T5956969、MurD-DB07296、MurG、MurG-CHEMBL468144 和 MurG-DB07296。基于全局和基本动力学分析,MurB(CHEMBL468144>DB07296)、MurD(Enamine_T5956969>DB07296)、MurE(54723243>DB07296)和 MurG(CHEMBL468144>DB07296)中分子的稳定性顺序表明,与现有抑制剂相比,新鉴定的分子更有前途。基于所有对接和 MD 模拟结果,自由和配体结合蛋白的稳定性顺序如下:MurB 和 MurB-配体复合物>MurD 和 MurD-配体复合物>MurG 和 MurG-配体复合物>MurE 和 MurE-配体复合物。最后,建议选择化合物进一步进行实验研究,并用作治疗鲍曼不动杆菌感染的有前途的抑制剂。